You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 12, December 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Ophthalmological Disorders, Other
 •Patient-Physician Relationship/ Care
 •Treatment Adherence
 •Statistics and Research Methods
 •Randomized Controlled Trial
 •Drug Therapy
 •Adherence
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Convergence Insufficiency: Randomized Clinical Trial

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

I read the article by Scheiman et al1 entitled "A Randomized Clinical Trial of Treatments for Convergence Insufficiency in Children" in the January 2005 issue of the ARCHIVES with great interest. I would like to congratulate Scheiman and colleagues for venturing into this area where, truly, not many randomized clinical trials have been done.

I would, however, like to raise some important issues regarding the entire study, particularly with reference to the treatment regimens. As Kushner2 has rightly pointed out, the intensive therapy that Scheiman and colleagues have provided for the treatment group is much more intensive than the therapy for home exercises. For example, a child in group 1 exercises for only a total of 15 hours (15 min/d for 12 weeks, although this could have been just 6-8.5 min/d) whereas a child in group 2 exercises for nearly 75 hours (an excess of 60 hours of the . . . [Full Text of this Article]


AUTHOR INFORMATION
Jitendra Jethani, MS, DO, DNB



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Convergence Insufficiency: Randomized Clinical Trial—Reply
Mitchell Scheiman, G. Lynn Mitchell, Susan Cotter, Jeffrey Cooper, Marjean Kulp, Michael Rouse, Eric Borsting, Richard London, Janice Wensveen, and the Convergence Insufficiency Treatment Trial (CITT) Study Group
Arch Ophthalmol. 2005;123(12):1760-1761.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.